 |
인쇄하기
취소
|
Ahngook wins Norvasc patent suit
Ahngook Pharm got more good news on September 24, as the company said the Supreme Court upheld the company's Korean patent covering the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
The Supreme Court has ruled in favor of Ahngook in a patent infringement suit involving Ahngook and Pfizer’s patents covering Novasc (amlodipine besylate)....
The Supreme Court has ruled in favor of Ahngook in a patent infringement suit involving Ahngook and Pfizer’s patents covering Novasc (amlodipine besylate)....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.